Αποτελέσματα αναζήτησης - Merin Jose
- Εμφανίζονται 1 - 2 Αποτελέσματα από 2
-
1
-
2
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom από Tim Spelman, William L. Herring, Carlos Acosta, Robert Hyde, Vilija Jokubaitis, Eugenio Pucci, Alessandra Lugaresi, Guy Laureys, Eva Havrdová, Dana Horáková, Guillermo Izquierdo, Sara Eichau, Serkan Özakbaş, Raed Alroughani, Tomáš Kalinčík, Pierre Duquette, Marc Girard, Thor Petersen, Francesco Patti, Tünde Csépány, Franco Granella, François Grand’Maison, Diana Ferraro, Rana Karabudak, Merin Jose, María Trojano, Vincent Van Pesch, B. Van Wijmeersch, Elisabetta Cartechini, Pamela McCombe, Oliver Gerlach, Daniele Spitaleri, Csilla Rózsa, Suzanne Hodgkinson, Roberto Bergamaschi, Riadh Gouider, Aysun Soysal, Castillo-Triviño, Julie Prévost, Jeffrey R. Garber, Koen de Gans, Radek Ampapa, M. Simó, José Luis Sánchez-Menoyo, Gerardo Iuliano, Attila Sas, Anneke van der Walt, Nevin John, Orla Gray, S. Hughes, Giovanna De Luca, Marco Onofrj, Katherine Buzzard, Olga Skibina, Murat Terzi, Mark Slee, Claudio Solaro, Oreja-Guevara, Cristina Ramo‐Tello, Yára Dadalti Fragoso, Vahid Shaygannejad, Fraser Moore, Cecília Rajda, Eduardo Agüera, Helmut Butzkueven
Έκδοση 2023Artigo
Εργαλεία αναζήτησης:
Σχετικά θέματα
Internal medicine
Medicine
Apolipoprotein B
Biology
Cholesterol
Cohort
Cost effectiveness
Environmental health
Etiology
Familial hypercholesterolemia
Fingolimod
Gene
Genetics
Genotype
Genotyping
Immunology
Intensive care medicine
LDL receptor
Lipoprotein
Multiple sclerosis
Natalizumab
PCSK9
Physical therapy
Population
Relapsing remitting
Risk analysis (engineering)